Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Complimentary trend analysis report: Emerging trends in pancreatic cancer research

Posted on September 17th, 2020 by

Pancreatic cancer sadly remains one of the most deadly cancers in existence, partly because it often goes undiagnosed until it has already metastasized. Finding new and better therapies to fight pancreatic cancer means accelerating the research. A new report just released from Elsevier’s Professional Services Group, titled Text mining to identify emerging trends in the pancreatic cancer literature, shows how that is possible.

(more…)

Insights begin with clean, reusable data

Posted on August 24th, 2020 by

Good data practices lead to better research outcomes. To learn more about why clean, reusable data is critical to R&D, take a look at this helpful new infographic that demonstrates how Entellect is centered around the importance of reusable data, irrespective of scientific domain.

(more…)

Predicting Cancer Drug Combinations That Work

Posted on August 6th, 2020 by

Dr. Bart Westerman is a Group Leader and Assistant Professor at the VU University Medical Center in Amsterdam. There he heads research projects in neuro-oncology, as well as in the use of bioinformatics to tackle complex, multidimensional questions to transform cancer therapy decision-making and management. He and his colleagues recently published a cancer drug atlas that predicts synergistic combination therapies for cancer.

(more…)

Research Data Alliance Releases Guidelines for COVID-19 Data Sharing

Posted on July 24th, 2020 by

The Research Data Alliance (RDA) has released its final version of the RDA COVID-19 Recommendations and Guidelines on data sharing for COVID-19, which covers four main research areas: clinical data, omics practices, epidemiology and social sciences. The document also touches on issues like community participation, legal and ethical considerations, research software and indigenous data.

(more…)

  1. 1
  2. 2
  3. 3
  4. 84